ASBMR 2016 Recap
Bisphosphonates, bone health and more: In this slideshow, we revisit some of the studies presented at the American Society for Bone and Mineral Research annual meeting, which took place Sept. 16-19 in Atlanta.
Romosozumab Shows Promise for Post-Menopausal Osteoporosis
Treating post-menopausal osteoporosis patients with romosozumab could improve their long-term bone density, a study shows.
Low Protein and Osteoporosis in Men?
Low protein intake may be responsible for fractures in older men, according to an observational study.
Fracture Assessment Tools Underutilized, Study Shows
Using the fracture assessment tool with older, community-dwelling women can help reduce their risk of hip fracture over time, study shows.
Hip Fractures No Longer on a Downward Trend in the U.S.
Osteoporosis-related hip fractures are no longer on a downward trend in the U.S. A drop in reimbursement for a common screening technique could be to blame.
How One Class of Bisphosphonates Could Predict Vertebral Fractures
Using biomarkers to assess drug efficacy could pave the way for improved osteoporosis treatment, according to a new study.
Screening is Lax in Glucocorticoid-Induced Osteoporosis
Some patients are not being screened or treated for glucocorticoid-induced osteoporosis by primary care physicians or rheumatologists.
By clicking Accept, you agree to become a member of the UBM Medica Community.